دورية أكاديمية
أعرض في EDS

Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension.

التفاصيل البيبلوغرافية
العنوان: Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension.
المؤلفون: Schutte AE; School of Population Health, University of New South Wales, Kensington Campus, High Street, Sydney 2052 NSW, Australia; The George Institute for Global Health, King Street, Newton, Sydney NSW 2052, Australia.; Hypertension in Africa Research Team, SAMRC Unit for Hypertension and Cardiovascular Disease; North-West University, Hoffman Street, Potchefstroom 2520, South Africa.; SAMRC Development Pathways for Health Research Unit, School of Clinical Medicine, University of the Witwatersrand, 1 Jan Smuts Ave, Braamfontein, Johannesburg, 2000, South Africa., Jafar TH; Program in Health Services and Systems Research, Duke-NUS Medical School, Department of Renal Medicine, 8 College Rd., Singapore 169857, Singapore.; Duke Global Health Institute, Duke University, 310 Trent Dr, Durham, NC 27710, USA., Poulter NR; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London W12 7RH, UK., Damasceno A; Faculty of Medicine, Eduardo Mondlane University, 3453 Avenida Julius Nyerere, Maputo, Mozambique., Khan NA; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Center for Health Evaluation and Outcomes Sciences, Vancouver, British Columbia, Canada., Nilsson PM; Department of Clinical Sciences, Skane University Hospital, Lund University, Malmö, Sweden., Alsaid J; Ochsner Health System, New Orleans, Louisiana, USA.; Queensland University, Brisbane, Queensland, Australia., Neupane D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Kario K; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan., Beheiry H; International University of Africa, Khartoum, Sudan., Brouwers S; Department of Cardiology, Cardiovascular Center Aalst, OLV Clinic Aalst, Aalst, Belgium.; Department of Experimental Pharmacology, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium., Burger D; Kidney Research Centre, Ottawa Hospital Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada., Charchar FJ; Health Innovation and Transformation Centre, Federation University, Ballarat, Victoria, Australia.; Department of Physiology and Anatomy, University of Melbourne, Melbourne, Victoria, Australia., Cho MC; Department of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju, Korea., Guzik TJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Haji Al-Saedi GF; Baghdad College of Medicine, Baghdad, Iraq., Ishaq M; Pakistan Hypertension League, Karachi, Pakistan., Itoh H; Department of Endocrinology, Metabolism and Nephrology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8585, Japan., Jones ESW; Division of Nephrology and Hypertension, Groote Schuur Hospital and Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa., Khan T; Department of Public Health Medicine, University of Pretoria, Pretoria, South Africa., Kokubo Y; Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan., Kotruchin P; Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Muxfeldt E; University Hospital Clementino Fraga Filho, Hypertension Program, Universidade Federal do Rio de Janeiro, Brazil., Odili A; Circulatory Health Research Laboratory, College of Health Sciences, University of Abuja, Abuja, Nigeria., Patil M; Department of Nutrition and Dietetics, Asha Kiran JHC Hospital, Chinchwad, India., Ralapanawa U; Faculty of Medicine, University of Peradeniya, Kandy, Central Province, Sri Lanka., Romero CA; Renal Division, Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA., Schlaich MP; Dobney Hypertension Centre, School of Medicine, Royal Perth Hospital Unit and RPH Research Foundation, The University of Western Australia, Perth, Australia.; Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia.; Department of Nephrology, Royal Perth Hospital, Perth, Western Australia, Perth, Western Australia, Australia., Shehab A; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates., Mooi CS; Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia., Steckelings UM; Department of Cardiovascular & Renal Research, Institute of Molecular Medicine. University of Southern Denmark, Odense, Denmark., Stergiou G; Hypertension Centre STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece., Touyz RM; Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada., Unger T; CARIM - Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands., Wainford RD; Department of Pharmacology & Experimental Therapeutics and the Whitaker, Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA., Wang JG; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Williams B; Institute of Cardiovascular Science, University College London (UCL), National Institute for Health Research (NIHR), UCL Hospitals Biomedical Research Centre, London, UK., Wynne BM; Department of Internal Medicine, Division of Nephrology & Hypertension, University of Utah, Salt Lake City, UT, USA., Tomaszewski M; Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.; Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
المصدر: Cardiovascular research [Cardiovasc Res] 2023 Mar 31; Vol. 119 (2), pp. 381-409.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
أسماء مطبوعة: Publication: 2008- : Oxford : Oxford Journals
Original Publication: London, British Medical Assn.
مواضيع طبية MeSH: COVID-19* , Hypertension*/diagnosis , Hypertension*/drug therapy , Hypertension*/epidemiology , Cardiovascular Diseases*, Humans ; Blood Pressure ; Income
مستخلص: Abstract: Raised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific. We report that most countries failed to show sufficient improvements in BP control rates over the past three decades, with greater improvements mainly seen in some high-income countries, also reflected in substantial reductions in the burden of cardiovascular disease and deaths. Globally, there are significant inequities and disparities based on resources, sociodemographic environment, and race with subsequent disproportionate hypertension-related outcomes. Additional unique challenges in specific regions include conflict, wars, migration, unemployment, rapid urbanization, extremely limited funding, pollution, COVID-19-related restrictions and inequalities, obesity, and excessive salt and alcohol intake. Immediate action is needed to address suboptimal hypertension care and related disparities on a global scale. We propose a Global Hypertension Care Taskforce including multiple stakeholders and societies to identify and implement actions in reducing inequities, addressing social, commercial, and environmental determinants, and strengthening health systems implement a well-designed customized quality-of-care improvement framework.
Competing Interests: Conflict of interest: A.E.S. received speaker honoraria from different pharmaceutical companies and device manufacturers for work unrelated to this paper; P.M.N. has received speaker honoraria from different pharmaceutical companies. K.K. reports research grants from A&D, Omron Healthcare, Fukuda Denshi, Otsuka Pharmaceutical, Otsuka Holdings, CureApp, Sanwa Kagaku Kenkyusho, Daiichi Sankyo, Taisho Pharmaceutical, Sumitomo Dainippon Pharma, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, Boehringer-Ingelheim Japan, Pfizer Japan, Fukuda Lifetec, Bristol-Myers Squibb, Mochida Pharmaceutical, Roche Diagnostics; and Consulting fees from A&D, JIMRO, Omron Healthcare, CureApp, Kyowa Kirin, Sanwa Kagaku Kenkyusho, Terumo, Fukuda Denshi, Mochida Pharmaceutical; and Honoraria from Idorsia, Omron Healthcare, Daiichi Sankyo, Novartis Pharma, Mylan EPD; and Participation in Advisory Board of Daiichi Sankyo, Novartis Pharma, Fukuda Denshi outside the submitted work. J.-G.W. reports having received lecture and consulting fees from Novartis, Omron, Servier, and Viatris. M.P.S. has received consulting fees, and/or travel and research support from Medtronic, Abbott, Metavention, ReCor, Novartis, Servier, Pfizer, and Boehringer-Ingelheim. E.S.W.J. has received honoraria from pharmaceutical companies for work unrelated to this publication. N.R.P. has received financial support from several pharmaceutical companies which manufacture BP-lowering agents, for consultancy fees (Servier), research projects, and staff (Servier, Pfizer) and for arranging and speaking at educational meetings (AstraZeneca, Lri Therapharma, Napi, Servier, Sanofi, Eva Pharma, Pfizer, Glenmark Pharma, Alkem Lab, and Emcure India). He holds no stocks and shares in any such companies. This manuscript was handled by Guest Editor Thomas F. Lüscher
(© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.)
References: Nihon Rinsho. 2005 Jun;63(6):952-8. (PMID: 15948375)
BMC Cardiovasc Disord. 2018 Mar 7;18(1):49. (PMID: 29514623)
Curr Hypertens Rep. 2014 Jun;16(6):437. (PMID: 24764197)
Am J Hypertens. 2018 Oct 15;31(11):1205-1214. (PMID: 29701801)
J Clin Hypertens (Greenwich). 2021 Mar;23(3):435-439. (PMID: 33484617)
J Am Heart Assoc. 2016 Jan 20;5(1):. (PMID: 26790695)
Lancet. 2021 Sep 11;398(10304):957-980. (PMID: 34450083)
Circ Res. 2021 Apr 2;128(7):808-826. (PMID: 33793340)
Hypertension. 2013 Feb;61(2):278-83. (PMID: 23248146)
Trop Med Int Health. 2010 Mar;15(3):350-61. (PMID: 20070634)
Am J Hypertens. 2016 Dec 1;29(12):1343-1352. (PMID: 27543330)
Ethn Dis. 2003 Summer;13(2 Suppl 2):S97-101. (PMID: 13677422)
Eur Heart J. 2020 Jan 1;41(1):12-85. (PMID: 31820000)
J Am Heart Assoc. 2020 Jun 16;9(12):e015031. (PMID: 32476602)
Lancet. 2019 Aug 24;394(10199):637-638. (PMID: 31320200)
Hypertension. 2018 May;71(5):824-832. (PMID: 29555664)
Cochrane Database Syst Rev. 2016 Sep 16;9:CD010166. (PMID: 27633834)
Lancet. 2016 Nov 26;388(10060):2665-2712. (PMID: 27671667)
BMJ Open. 2017 Mar 31;7(3):e013817. (PMID: 28363924)
JMIR Res Protoc. 2020 Apr 9;9(4):e15933. (PMID: 32271155)
J Glob Health. 2019 Dec;9(2):020315. (PMID: 31656602)
Hypertension. 2020 Aug;76(2):333-341. (PMID: 32419505)
Hypertension. 2016 Sep;68(3):e7-e46. (PMID: 27443572)
Circulation. 2018 Oct 23;138(17):e484-e594. (PMID: 30354654)
Am J Hypertens. 2013 Jul;26(7):879-87. (PMID: 23512697)
JAMA. 2014 Feb 5;311(5):507-20. (PMID: 24352797)
Lancet. 2016 Jul 30;388(10043):465-75. (PMID: 27216139)
Hypertension. 2021 Feb;77(2):308-318. (PMID: 33390043)
Eur Heart J. 2022 Sep 14;43(35):3352-3361. (PMID: 34643681)
BMJ. 2004 Mar 13;328(7440):634-40. (PMID: 15016698)
J Hypertens. 2020 Jun;38(6):982-1004. (PMID: 32371787)
J Clin Hypertens (Greenwich). 2020 Mar;22(3):438-444. (PMID: 31851429)
Glob Heart. 2020 Jul 30;15(1):50. (PMID: 32923344)
N Engl J Med. 2022 Jan 20;386(3):252-263. (PMID: 34767706)
Nutr Metab Cardiovasc Dis. 2014 Dec;24(12):1253-61. (PMID: 25149893)
Can J Cardiol. 2021 May;37(5):744-755. (PMID: 33310142)
Lancet. 2020 Oct 17;396(10258):1223-1249. (PMID: 33069327)
Circulation. 2005 Mar 15;111(10):1278-83. (PMID: 15769769)
N Engl J Med. 2020 Jun 18;382(25):e99. (PMID: 32558482)
JAMA. 2017 Sep 19;318(11):1016-1025. (PMID: 28975305)
Lancet Glob Health. 2018 Jul;6(7):e736-e743. (PMID: 29778399)
Lancet Glob Health. 2021 May;9(5):e660-e667. (PMID: 33751956)
Lancet Glob Health. 2019 Oct;7(10):e1367-e1374. (PMID: 31537367)
J Hypertens. 2003 Nov;21(11):1983-92. (PMID: 14597836)
Eur Heart J. 2017 Apr 1;38(13):983-990. (PMID: 28417138)
Hypertension. 2022 Jan;79(1):293-301. (PMID: 34775787)
Circulation. 2014 Apr 8;129(14):1483-92. (PMID: 24573352)
J Clin Hypertens (Greenwich). 2021 Oct;23(10):1815-1829. (PMID: 34498797)
Ann Intern Med. 2009 Nov 3;151(9):593-601. (PMID: 19884620)
J Clin Hypertens (Greenwich). 2016 Jun;18(6):551-6. (PMID: 26459236)
J Am Heart Assoc. 2020 Oct 20;9(19):e016804. (PMID: 32975166)
Am J Med. 1972 May;52(5):653-63. (PMID: 5027555)
J Clin Hypertens (Greenwich). 2021 Apr;23(4):720-729. (PMID: 33369074)
Arch Intern Med. 1999 Feb 8;159(3):285-93. (PMID: 9989541)
Hypertens Res. 2014 Apr;37(4):253-390. (PMID: 24705419)
Nat Rev Cardiol. 2021 Nov;18(11):785-802. (PMID: 34050340)
JAMA Netw Open. 2021 Apr 1;4(4):e213718. (PMID: 33904917)
J Hypertens. 2007 Jun;25(6):1105-87. (PMID: 17563527)
Hypertens Res. 2022 Jan;45(1):1-2. (PMID: 34750504)
Lancet Public Health. 2017 Feb;2(2):e108-e120. (PMID: 29253389)
Lancet. 2014 May 31;383(9932):1912-9. (PMID: 24881995)
J Hypertens. 2013 Jul;31(7):1281-357. (PMID: 23817082)
Telemed J E Health. 2010 Sep;16(7):830-8. (PMID: 20815751)
Circulation. 2005 Mar 15;111(10):1291-7. (PMID: 15769771)
BMJ. 2010 Jun 07;340:c2641. (PMID: 20530082)
Can J Cardiol. 2017 May;33(5):557-576. (PMID: 28449828)
Lancet. 2021 Jul 17;398(10296):249-261. (PMID: 34019821)
Hypertension. 2021 Sep;78(3):779-786. (PMID: 34379437)
Hypertension. 2011 Oct;58(4):522-38. (PMID: 21859967)
Rev Panam Salud Publica. 2021 Feb 26;44:e27. (PMID: 33643393)
Blood Press Suppl. 2005 Dec;2:10-6. (PMID: 16429636)
BMJ. 2013 Apr 03;346:f1325. (PMID: 23558162)
Lancet. 2019 Aug 24;394(10199):652-662. (PMID: 31327566)
N Engl J Med. 2020 Feb 20;382(8):717-726. (PMID: 32074419)
J Migr Health. 2021 Mar 19;3:100035. (PMID: 34405185)
JAMA. 2020 Jun 23;323(24):2454. (PMID: 32573675)
Lancet. 2011 Feb 12;377(9765):568-77. (PMID: 21295844)
Can J Cardiol. 2019 May;35(5):582-589. (PMID: 31030861)
J Hypertens. 2020 Jul;38(7):1235-1243. (PMID: 31990898)
J Clin Hypertens (Greenwich). 2020 Mar;22(3):423-430. (PMID: 31955506)
Glob Heart. 2021 Sep 10;16(1):63. (PMID: 34692387)
Adv Nutr. 2020 Sep 1;11(5):1150-1160. (PMID: 32330233)
J Clin Hypertens (Greenwich). 2020 Mar;22(3):351-362. (PMID: 31816164)
Heart. 2013 May;99(10):715-21. (PMID: 23403406)
Circulation. 2020 Nov 10;142(19):1821-1830. (PMID: 33019798)
Lancet Glob Health. 2018 Jan;6(1):e66-e73. (PMID: 29241617)
Hypertension. 2006 Feb;47(2):296-308. (PMID: 16434724)
Lancet Glob Health. 2018 Mar;6(3):e342-e350. (PMID: 29396220)
BMJ Open. 2013 Dec 23;3(12):e003733. (PMID: 24366578)
Med J Aust. 2022 Feb 7;216(2):61-63. (PMID: 34865237)
Hypertension. 2017 Nov;70(5):1042-1048. (PMID: 28847892)
N Engl J Med. 1997 Apr 17;336(16):1117-24. (PMID: 9099655)
J Am Heart Assoc. 2021 Jun;10(11):e020997. (PMID: 34006116)
Ther Adv Cardiovasc Dis. 2009 Aug;3(4):259-85. (PMID: 19561117)
Lancet. 2019 Aug 24;394(10199):639-651. (PMID: 31327564)
PLoS Med. 2013;10(7):e1001490. (PMID: 23935461)
PLoS Med. 2017 Feb 14;14(2):e1002232. (PMID: 28196089)
J Clin Hypertens (Greenwich). 2020 Mar;22(3):331-343. (PMID: 31773883)
Hypertension. 2020 Jun;75(6):1334-1357. (PMID: 32370572)
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2023-2032. (PMID: 33975737)
Hypertens Res. 2009 Jan;32(1):3-107. (PMID: 19300436)
Front Cardiovasc Med. 2016 Feb 23;3:3. (PMID: 26942184)
JAMA. 2003 May 21;289(19):2560-72. (PMID: 12748199)
Int J Cardiol Hypertens. 2020 Oct 26;7:100061. (PMID: 33447782)
N Engl J Med. 2014 Aug 14;371(7):624-34. (PMID: 25119608)
BMJ Open. 2019 Aug 27;9(8):e029001. (PMID: 31462473)
BMC Health Serv Res. 2017 Feb 13;17(1):135. (PMID: 28193217)
NCHS Data Brief. 2017 Apr;(278):1-8. (PMID: 28463104)
J Am Soc Hypertens. 2016 Nov;10(11):829-837. (PMID: 27720143)
NCHS Data Brief. 2020 Apr;(364):1-8. (PMID: 32487290)
Blood Press. 2011 Dec;20(6):348-54. (PMID: 21675827)
Hypertension. 2021 Nov;78(5):1161-1167. (PMID: 34510915)
Hypertension. 2020 Oct;76(4):1028-1037. (PMID: 32816574)
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD005182. (PMID: 20238338)
J Am Coll Cardiol. 2019 Oct 15;74(15):1897-1906. (PMID: 31487546)
Can J Cardiol. 2014 May;30(5):544-52. (PMID: 24786445)
J Epidemiol Community Health. 2021 Aug;75(8):710-711. (PMID: 33849922)
N Engl J Med. 2021 Sep 30;385(14):1268-1279. (PMID: 34491661)
Hypertension. 2018 Aug;72(2):263-269. (PMID: 29941519)
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1442-1449. (PMID: 31544349)
Global Health. 2019 Jul 11;15(1):46. (PMID: 31296242)
Lancet. 2020 Jul 11;396(10244):97-109. (PMID: 32445693)
PLoS Med. 2020 Jan 2;17(1):e1002997. (PMID: 31895945)
N Engl J Med. 2001 Jan 4;344(1):3-10. (PMID: 11136953)
Pak J Med Sci. 2020 Nov-Dec;36(7):1719-1725. (PMID: 33235604)
BMJ. 2021 Jan 19;372:m4858. (PMID: 33468518)
Health Psychol Open. 2019 Nov 12;6(2):2055102919885752. (PMID: 31763049)
BMJ. 2021 Jan 14;372:m4921. (PMID: 33446485)
Arch Intern Med. 1998 Jun 8;158(11):1197-207. (PMID: 9625399)
Lancet Glob Health. 2016 Oct;4(10):e695-703. (PMID: 27567348)
Nutrients. 2017 Aug 03;9(8):. (PMID: 28771193)
Am J Hypertens. 1996 Jan;9(1):1-11. (PMID: 8834700)
J Hypertens. 2003 Jun;21(6):1011-53. (PMID: 12777938)
J Am Heart Assoc. 2020 May 5;9(9):e015302. (PMID: 32338557)
Circ Res. 2021 Apr 2;128(7):827-846. (PMID: 33793326)
Arch Intern Med. 1993 Jan 25;153(2):154-83. (PMID: 8422206)
JAMA. 2013 Sep 4;310(9):959-68. (PMID: 24002282)
Hypertension. 2017 Jun;69(6):1113-1120. (PMID: 28461599)
Eur Heart J. 2011 Jun;32(11):1424-31. (PMID: 21487117)
Hypertension. 2021 Sep;78(3):564-577. (PMID: 34225469)
J Am Coll Cardiol. 2019 Jun 18;73(23):3018-3026. (PMID: 31196460)
N Engl J Med. 2021 Sep 16;385(12):1067-1077. (PMID: 34459569)
Eur Heart J. 2018 Sep 1;39(33):3021-3104. (PMID: 30165516)
PLoS One. 2016 May 18;11(5):e0155699. (PMID: 27192051)
Int J Epidemiol. 2002 Feb;31(1):240-7. (PMID: 11914327)
Med Sci Sports Exerc. 2019 Jun;51(6):1314-1323. (PMID: 31095088)
Can J Cardiol. 2005 Jun;21(8):645-56. (PMID: 16003448)
Glob Heart. 2016 Jun;11(2):207-12. (PMID: 27242088)
N Engl J Med. 2000 Jan 20;342(3):145-53. (PMID: 10639539)
J Am Soc Hypertens. 2014 Jun;8(6):437-47. (PMID: 24952655)
N Engl J Med. 2018 Apr 05;378(14):1291-1301. (PMID: 29527973)
J Hypertens. 2017 Oct;35(10):2102-2108. (PMID: 28582282)
Circulation. 2019 Aug 27;140(9):715-725. (PMID: 31177824)
PLoS One. 2014 Jan 31;9(1):e86837. (PMID: 24497983)
Lancet Diabetes Endocrinol. 2021 Jul;9(7):462-470. (PMID: 33865500)
Hypertens Res. 2020 Nov;43(11):1133-1134. (PMID: 32475981)
J Hum Hypertens. 1998 Feb;12(2):91-110. (PMID: 9504351)
Lancet. 2022 May 21;399(10339):1964-1975. (PMID: 35500594)
Int J Epidemiol. 2006 Feb;35(1):105-11. (PMID: 16258058)
PLoS One. 2017 Sep 13;12(9):e0183033. (PMID: 28902880)
Can J Cardiol. 2020 May;36(5):732-739. (PMID: 32299635)
PLoS Med. 2017 Sep 19;14(9):e1002389. (PMID: 28926573)
Adv Nutr. 2020 May 1;11(3):677-686. (PMID: 31904809)
Lancet. 2017 Jan 7;389(10064):37-55. (PMID: 27863813)
Ann Intern Med. 2002 Apr 2;136(7):493-503. (PMID: 11926784)
Medicine (Baltimore). 2017 Jan;96(4):e5641. (PMID: 28121920)
BMJ Glob Health. 2020 Nov;5(11):. (PMID: 33168520)
Hypertension. 2020 Nov;76(5):1368-1383. (PMID: 32921195)
PLoS One. 2015 Jul 22;10(7):e0130247. (PMID: 26201031)
Ann Intern Med. 2018 Jan 16;168(2):110-120. (PMID: 29277852)
J Clin Hypertens (Greenwich). 2021 Apr;23(4):713-719. (PMID: 33458931)
Hypertension. 2014 Apr;63(4):878-85. (PMID: 24243703)
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):. (PMID: 28096206)
Prev Chronic Dis. 2018 Jun 07;15:E73. (PMID: 29885674)
J Clin Hypertens (Greenwich). 2018 Jul;20(7):1089-1091. (PMID: 30003695)
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):1009-60. (PMID: 10423121)
Hypertension. 2018 Nov;72(5):1117-1124. (PMID: 30354817)
J Hypertens. 2020 Jun;38(6):1183-1188. (PMID: 32371809)
Lancet. 2017 Dec 2;390(10111):2516-2526. (PMID: 28314568)
J Hum Hypertens. 2001 Apr;15(4):263-9. (PMID: 11319675)
Hypertens Res. 2019 Sep;42(9):1235-1481. (PMID: 31375757)
J Clin Hypertens (Greenwich). 2017 Aug;19(8):746-752. (PMID: 28429879)
Circulation. 2016 Aug 9;134(6):441-50. (PMID: 27502908)
BMC Public Health. 2014 May 01;14:414. (PMID: 24885860)
Circulation. 2016 Jun 7;133(23):2314-33. (PMID: 27267538)
Lancet. 2019 Jul 27;394(10195):345-356. (PMID: 31303318)
Lancet Glob Health. 2019 Oct;7(10):e1359-e1366. (PMID: 31477545)
N Engl J Med. 2020 Nov 26;383(22):e121. (PMID: 33064382)
J Hum Hypertens. 2022 May;36(5):428-436. (PMID: 34075186)
JACC Asia. 2021 Jun 15;1(1):1-13. (PMID: 36338365)
Arch Intern Med. 2010 Sep 13;170(16):1501-2. (PMID: 20837839)
J Hum Hypertens. 2015 Apr;29(4):247-53. (PMID: 25273858)
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26. (PMID: 24341872)
Can J Cardiol. 2020 May;36(5):596-624. (PMID: 32389335)
Hypertension. 2009 Mar;53(3):480-6. (PMID: 19204180)
Lancet. 2003 Nov 8;362(9395):1527-35. (PMID: 14615107)
Curr Cardiol Rep. 2017 Oct 28;19(12):129. (PMID: 29081008)
معلومات مُعتمدة: MR/N006178/1 United Kingdom MRC_ Medical Research Council; MR/L004224/1 United Kingdom MRC_ Medical Research Council; MRF_MRF-145-0008-DG-JAFA-C0862 United Kingdom MRF MRF; United Kingdom BHF_ British Heart Foundation
فهرسة مساهمة: Keywords: Awareness; Cardiovascular disease; Control; Epidemiology; Global; Hypertension; Inequity; International; Prevention; Regions; Treatment
تواريخ الأحداث: Date Created: 20221011 Date Completed: 20230404 Latest Revision: 20230818
رمز التحديث: 20230818
مُعرف محوري في PubMed: PMC9619669
DOI: 10.1093/cvr/cvac130
PMID: 36219457
قاعدة البيانات: MEDLINE
الوصف
تدمد:1755-3245
DOI:10.1093/cvr/cvac130